Trials / Unknown
UnknownNCT00505102
Safe Renal Function In Long Term Heart Transplanted Patients
Efficacy and Safety of Everolimus to SAve REnal Function (SAREFU) in Long Term Heart Transplanted Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- A.O. Ospedale Papa Giovanni XXIII · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to verify whether the reduction of cyclosporine dosages associated with Everolimus administration may improve renal function as compared to patients maintained on standard immunosuppressive therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Everolimus | cyclosporine dose reduced of 50% after introduction of everolimus |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2007-07-20
- Last updated
- 2008-02-13
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00505102. Inclusion in this directory is not an endorsement.